Journal of Antimicrobial Chemotherapy (2002) 49, 103-111
© 2002 The British Society for Antimicrobial Chemotherapy
In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis
Romark Research Laboratory, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK
The activities of the N-(nitrothiazolyl) salicylamide nitazoxanide and its metabolite tizoxanide were compared with metronidazole in vitro in microplates against six axenic isolates of Giardia intestinalis. Tizoxanide was eight times more active than metronidazole against metronidazole-susceptible isolates and twice as active against a resistant isolate. In 10 axenic isolates of Entamoeba histolytica, while tizoxanide was almost twice as active as metronidazole against more susceptible isolates, it was more than twice as active against less susceptible isolates. Fourteen metronidazole-susceptible isolates of Trichomonas vaginalis were 1.5 times more susceptible to tizoxanide, which was nearly five times as active against resistant isolates. Two highly metronidazole-resistant isolates retained complete susceptibility to tizoxanide, and one moderately resistant isolate showed reduced susceptibility. In all three organisms, nitazoxanide results paralleled those of tizoxanide. Analogues lacking the reducible nitro-group had similar low activities against susceptible G. intestinalis, E. histolytica and T. vaginalis, indicating that nitro-reduction and free radical production was a probable mode of action. Nitazoxanide and its metabolite tizoxanide are more active in vitro than metronidazole against G. intestinalis, E. histolytica and T. vaginalis. Although, like metronidazole, they depend on the presence of a nitro-group for activity, they retain some activity against metronidazole-resistant strains, particularly of T. vaginalis. The results suggest that resistance mechanisms for metronidazole can be bypassed by nitazoxanide and tizoxanide.
* Corresponding author. Tel: +44-20-7927-2341; Fax: +44-20-7637-0248; E-mail: d.warhurst{at}lshtm.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Tiwari, D. Singh, and M. M. Singh Anti-Trichomonas activity of Sapindus saponins, a candidate for development as microbicidal contraceptive J. Antimicrob. Chemother., September 1, 2008; 62(3): 526 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Muller, S. Ley, I. Felger, A. Hemphill, and N. Muller Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole J. Antimicrob. Chemother., July 1, 2008; 62(1): 72 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Muller, M. Sterk, A. Hemphill, and N. Muller Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole J. Antimicrob. Chemother., August 1, 2007; 60(2): 280 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Muller, J. Wastling, S. Sanderson, N. Muller, and A. Hemphill A Novel Giardia lamblia Nitroreductase, GlNR1, Interacts with Nitazoxanide and Other Thiazolides Antimicrob. Agents Chemother., June 1, 2007; 51(6): 1979 - 1986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Hoffman, G. Sisson, M. A. Croxen, K. Welch, W. D. Harman, N. Cremades, and M. G. Morash Antiparasitic Drug Nitazoxanide Inhibits the Pyruvate Oxidoreductases of Helicobacter pylori, Selected Anaerobic Bacteria and Parasites, and Campylobacter jejuni Antimicrob. Agents Chemother., March 1, 2007; 51(3): 868 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Ali and T. Nozaki Current Therapeutics, Their Problems, and Sulfur-Containing-Amino-Acid Metabolism as a Novel Target against Infections by "Amitochondriate" Protozoan Parasites Clin. Microbiol. Rev., January 1, 2007; 20(1): 164 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Reuter, B. Manfras, M. Merkle, G. Harter, and P. Kern In Vitro Activities of Itraconazole, Methiazole, and Nitazoxanide versus Echinococcus multilocularis Larvae. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 2966 - 2970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Blaha, M. Duchene, H. Aspock, and J. Walochnik In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis J. Antimicrob. Chemother., February 1, 2006; 57(2): 273 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Muller, G. Ruhle, N. Muller, J.-F. Rossignol, and A. Hemphill In Vitro Effects of Thiazolides on Giardia lamblia WB Clone C6 Cultured Axenically and in Coculture with Caco2 Cells Antimicrob. Agents Chemother., January 1, 2006; 50(1): 162 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Cudmore, K. L. Delgaty, S. F. Hayward-McClelland, D. P. Petrin, and G. E. Garber Treatment of Infections Caused by Metronidazole-Resistant Trichomonas vaginalis Clin. Microbiol. Rev., October 1, 2004; 17(4): 783 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Nitazoxanide Journal Watch Infectious Diseases, May 23, 2003; 2003(523): 11 - 11. [Full Text]
|
|